EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of garenoxacin in patients with macrolide-resistant Mycoplasma pneumoniae pneumonia

Naoyuki Miyashita iD, Makoto Ogata, Naoki Fukuda, Akihisa Yamura, Tomoki Ito

Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)

DOI: 10.1128/aac.00025-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Naoyuki Miyashita und 4 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Hirakata, Jap…. Hauptthemen laut MEDLINE: Mycoplasma pneumoniae, Anti-Bacterial Agents, Macrolides, Fluoroquinolones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of macrolide-resistant Mycoplasma pneumoniae in Japan is increasing once again. The therapeutic efficacy of quinolone garenoxacin was compared with minocycline, which is recommended as the first-choice drug in patients with macrolide-resistant M. pneumoniae pneumonia. Defervescence within 48 h after initiation of antibiotics was observed in 90.6% of garenoxacin and 90% of minocycline recipients. Our results indicated that garenoxacin can be considered as the first-choice drug for the treatment of macrolide-resistant M. pneumoniae pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma pneumoniaeAnti-Bacterial AgentsMacrolidesFluoroquinolonesPneumonia, MycoplasmaHumansMinocyclineDrug Resistance, BacterialMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Mycoplasma pneumoniaegarenoxacinmacrolide-resistancemacrolide-sensitiveminocycline

Substanzen

garenoxacinAnti-Bacterial AgentsMacrolidesFluoroquinolonesMinocycline

Autor:innen und Institutionen

  • First Department of Internal Medicine, Division of Respiratory Medicine, Infectious Disease and Allergology, Kansai Medical University, Hirakata, Japan.

ORCID-Profile: Naoyuki Miyashita

Zitieren

APA

Miyashita, N., Ogata, M., Fukuda, N., Yamura, A., & Ito, T. (2026). Efficacy of garenoxacin in patients with macrolide-resistant Mycoplasma pneumoniae pneumonia. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.00025-26

Vancouver

Miyashita N, Ogata M, Fukuda N, Yamura A, Ito T. Efficacy of garenoxacin in patients with macrolide-resistant Mycoplasma pneumoniae pneumonia. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.00025-26

BibTeX
@article{Miyashita2026,
  author = {Miyashita, Naoyuki and Ogata, Makoto and Fukuda, Naoki and Yamura, Akihisa and Ito, Tomoki},
  title = {Efficacy of garenoxacin in patients with macrolide-resistant Mycoplasma pneumoniae pneumonia},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {7},
  doi = {10.1128/aac.00025-26}
}
Kostenlos starten →